SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10–K
 
 
X


Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2005 or

Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

 
 
MERIT MEDICAL SYSTEMS, INC.

(Exact name of registrant as specified in its charter)
 
Utah

(State or other jurisdiction
of incorporation)
0–18592

(Commission File No.)
87–0447695

(IRS Employer
Identification No.)
 

1600 West Merit Parkway
South Jordan, Utah 84095


(Address of principal executive offices, including zip code)
Registrant's telephone number, including area code: (801) 253–1600
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act:
Title of Class: Common Stock, No Par Value

Indicate by check mark if the registrant is a well-known seasonal issuer, as defined in Rule 405 of the Securities Act. Yes __   No  X 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes __   No  X 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes X   No __

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S–K is not contained herein, and will not be contained, to the best of the Registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10–K or any amendment to this Form 10-K.   X

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer (as defined in rule 12b-2 of the Act) or a non-accelerated filer (Check one): Large accelerated filer ___  Accelerated filer  X 
 Non-accelerated filer ___

Indicate by check mark whether the registrant is an accelerated filer (as defined in rule 12b-2 of the Act)   Yes X   No

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes __   No  X 

The aggregate market value of the Common Stock held by non–affiliates of the Registrant, on June 30, 2005, which is the last day of the Registrant’s most recently completed second fiscal quarter (based upon the closing sale price of the Common Stock on the NASDAQ National Market System on June 30, 2005), was approximately $386 million. Shares of Common Stock held by each officer and director and by each person who may be deemed to be an affiliate have been excluded.

As of March 2, 2006, the Registrant had 27,207,221 shares of Common Stock outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the following document are incorporated by reference in Part III of this Report: the Registrant’s definitive Proxy Statement relating to the Annual Meeting of Shareholders scheduled for May 25, 2006.

 

13